Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells.

Nature cell biology | Nov 3, 2010

http://www.ncbi.nlm.nih.gov/pubmed/20972423

Endothelial cells establish an instructive vascular niche that reconstitutes haematopoietic stem and progenitor cells (HSPCs) through release of specific paracrine growth factors, known as angiocrine factors. However, the mechanism by which endothelial cells balance the rate of proliferation and lineage-specific differentiation of HSPCs is unknown. Here, we demonstrate that Akt activation in endothelial cells, through recruitment of mTOR, but not the FoxO pathway, upregulates specific angiocrine factors that support expansion of CD34(-)Flt3(-) KLS HSPCs with long-term haematopoietic stem cell (LT-HSC) repopulation capacity. Conversely, co-activation of Akt-stimulated endothelial cells with p42/44 MAPK shifts the balance towards maintenance and differentiation of the HSPCs. Selective activation of Akt1 in the endothelial cells of adult mice increased the number of colony forming units in the spleen and CD34(-)Flt3(-) KLS HSPCs with LT-HSC activity in the bone marrow, accelerating haematopoietic recovery. Therefore, the activation state of endothelial cells modulates reconstitution of HSPCs through the modulation of angiocrine factors, with Akt-mTOR-activated endothelial cells supporting the self-renewal of LT-HSCs and expansion of HSPCs, whereas MAPK co-activation favours maintenance and lineage-specific differentiation of HSPCs.

Pubmed ID: 20972423 RIS Download

Mesh terms: Animals | Cell Communication | Cell Differentiation | Cell Lineage | Cell Proliferation | Cells, Cultured | Endothelial Cells | Enzyme Activation | Hematopoiesis | Hematopoietic Stem Cells | Humans | Mice | Mice, Inbred C57BL | Mice, Transgenic | Mitogen-Activated Protein Kinases | Paracrine Communication | Proto-Oncogene Proteins c-akt | TOR Serine-Threonine Kinases | Transforming Growth Factors

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, Id: HL097797
  • Agency: NHLBI NIH HHS, Id: P01 HL059312
  • Agency: NHLBI NIH HHS, Id: P01 HL059312-090006
  • Agency: NHLBI NIH HHS, Id: P01 HL059312-100006
  • Agency: NHLBI NIH HHS, Id: P50 HL084936
  • Agency: NHLBI NIH HHS, Id: P50 HL084936-010003
  • Agency: NHLBI NIH HHS, Id: P50 HL084936-020003
  • Agency: NHLBI NIH HHS, Id: P50 HL084936-030003
  • Agency: NHLBI NIH HHS, Id: P50 HL084936-040003
  • Agency: NHLBI NIH HHS, Id: R01 HL075234
  • Agency: NHLBI NIH HHS, Id: R01 HL075234-01
  • Agency: NHLBI NIH HHS, Id: R01 HL075234-02
  • Agency: NHLBI NIH HHS, Id: R01 HL075234-03
  • Agency: NHLBI NIH HHS, Id: R01 HL075234-04
  • Agency: NHLBI NIH HHS, Id: R01 HL097797
  • Agency: NHLBI NIH HHS, Id: R01 HL097797-01
  • Agency: NHLBI NIH HHS, Id: R01 HL097797-02
  • Agency: NHLBI NIH HHS, Id: R01 HL097797-03
  • Agency: NHLBI NIH HHS, Id: R21 HL083222
  • Agency: NHLBI NIH HHS, Id: R21 HL083222-01
  • Agency: NHLBI NIH HHS, Id: R21 HL083222-02
  • Agency: NIAID NIH HHS, Id: RC1 AI080309
  • Agency: NIAID NIH HHS, Id: RC1 AI080309
  • Agency: NIAID NIH HHS, Id: RC1 AI080309-01
  • Agency: NHLBI NIH HHS, Id: U01 HL066952
  • Agency: NHLBI NIH HHS, Id: U01 HL066952-010002
  • Agency: NHLBI NIH HHS, Id: U01 HL066952-020002
  • Agency: NHLBI NIH HHS, Id: U01 HL066952-030002
  • Agency: NHLBI NIH HHS, Id: U01 HL066952-040002
  • Agency: NHLBI NIH HHS, Id: U01 HL066952-050002
  • Agency: NHLBI NIH HHS, Id: U01 HL66592-03
  • Agency: Howard Hughes Medical Institute, Id:
  • Agency: Howard Hughes Medical Institute, Id:

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.